These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23650533)

  • 1. LPLUNC1 inhibits nasopharyngeal carcinoma cell growth via down-regulation of the MAP kinase and cyclin D1/E2F pathways.
    Yang Y; Liao Q; Wei F; Li X; Zhang W; Fan S; Shi L; Li X; Gong Z; Ma J; Zhou M; Xiang J; Peng S; Xiang B; Deng H; Yang Y; Li Y; Xiong W; Zeng Z; Li G
    PLoS One; 2013; 8(5):e62869. PubMed ID: 23650533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LPLUNC1 suppresses IL-6-induced nasopharyngeal carcinoma cell proliferation via inhibiting the Stat3 activation.
    Liao Q; Zeng Z; Guo X; Li X; Wei F; Zhang W; Li X; Chen P; Liang F; Xiang B; Ma J; Wu M; Tang H; Deng M; Zeng X; Tang K; Xiong W; Li G
    Oncogene; 2014 Apr; 33(16):2098-109. PubMed ID: 23708661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Knockdown of c-Myc inhibits cell proliferation by negatively regulating the Cdk/Rb/E2F pathway in nasopharyngeal carcinoma cells.
    Niu Z; Liu H; Zhou M; Wang H; Liu Y; Li X; Xiong W; Ma J; Li X; Li G
    Acta Biochim Biophys Sin (Shanghai); 2015 Mar; 47(3):183-91. PubMed ID: 25630654
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LPLUNC1 stabilises PHB1 by counteracting TRIM21-mediated ubiquitination to inhibit NF-κB activity in nasopharyngeal carcinoma.
    Wang H; Zhou Y; Oyang L; Han Y; Xia L; Lin J; Tang Y; Su M; Tan S; Tian Y; Chen X; Luo X; Liang J; Rao S; Wang Y; Xiong W; Zeng Z; Wang H; Li G; Liao Q
    Oncogene; 2019 Jun; 38(25):5062-5075. PubMed ID: 30886235
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LPLUNC1 reduces glycolysis in nasopharyngeal carcinoma cells through the PHB1-p53/c-Myc axis.
    Oyang L; Ouyang L; Yang L; Lin J; Xia L; Tan S; Wu N; Han Y; Yang Y; Li J; Chen X; Tang Y; Su M; Luo X; Li J; Xiong W; Zeng Z; Liao Q; Zhou Y
    Cancer Sci; 2023 Mar; 114(3):870-884. PubMed ID: 36382614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BPIFB1 (LPLUNC1) inhibits migration and invasion of nasopharyngeal carcinoma by interacting with VTN and VIM.
    Wei F; Wu Y; Tang L; He Y; Shi L; Xiong F; Gong Z; Guo C; Li X; Liao Q; Zhang W; Zhou M; Xiang B; Li X; Li Y; Li G; Xiong W; Zeng Z
    Br J Cancer; 2018 Jan; 118(2):233-247. PubMed ID: 29123267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. S100A6 promotes cell proliferation in human nasopharyngeal carcinoma via the p38/MAPK signaling pathway.
    Li A; Shi D; Xu B; Wang J; Tang YL; Xiao W; Shen G; Deng W; Zhao C
    Mol Carcinog; 2017 Mar; 56(3):972-984. PubMed ID: 27596819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic mediated zinc finger protein 671 downregulation promotes cell proliferation and tumorigenicity in nasopharyngeal carcinoma by inhibiting cell cycle arrest.
    Zhang J; Wen X; Liu N; Li YQ; Tang XR; Wang YQ; He QM; Yang XJ; Zhang PP; Ma J; Sun Y
    J Exp Clin Cancer Res; 2017 Oct; 36(1):147. PubMed ID: 29052525
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of aberrant cell cycle regulation in Epstein-Barr virus-associated nasopharyngeal carcinoma by cDNA microarray and gene set enrichment analysis.
    Zhang W; Zeng Z; Zhou Y; Xiong W; Fan S; Xiao L; Huang D; Li Z; Li D; Wu M; Li X; Shen S; Wang R; Cao L; Tang K; Li G
    Acta Biochim Biophys Sin (Shanghai); 2009 May; 41(5):414-28. PubMed ID: 19430707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. NAP1L1 targeting suppresses the proliferation of nasopharyngeal carcinoma.
    Liu Y; Li X; Zhang Y; Tang Y; Fang W; Liu X; Liu Z
    Biomed Pharmacother; 2021 Nov; 143():112096. PubMed ID: 34563951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lactotransferrin: a candidate tumor suppressor-Deficient expression in human nasopharyngeal carcinoma and inhibition of NPC cell proliferation by modulating the mitogen-activated protein kinase pathway.
    Zhou Y; Zeng Z; Zhang W; Xiong W; Wu M; Tan Y; Yi W; Xiao L; Li X; Huang C; Cao L; Tang K; Li X; Shen S; Li G
    Int J Cancer; 2008 Nov; 123(9):2065-72. PubMed ID: 18697201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MiR-663, a microRNA targeting p21(WAF1/CIP1), promotes the proliferation and tumorigenesis of nasopharyngeal carcinoma.
    Yi C; Wang Q; Wang L; Huang Y; Li L; Liu L; Zhou X; Xie G; Kang T; Wang H; Zeng M; Ma J; Zeng Y; Yun JP
    Oncogene; 2012 Oct; 31(41):4421-33. PubMed ID: 22249270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Forkhead Box Protein M1 Promotes Nasopharyngeal Carcinoma Cell Tumorigenesis Possibly via the Wnt/β-Catenin Signaling Pathway.
    Yu C; Chen H; Zhao Y; Zhang Y
    Med Sci Monit; 2021 Dec; 27():e931970. PubMed ID: 34911926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-16 induction after CDK4 knockdown is mediated by c-Myc suppression and inhibits cell growth as well as sensitizes nasopharyngeal carcinoma cells to chemotherapy.
    Jiang Q; Zhang Y; Zhao M; Li Q; Chen R; Long X; Fang W; Liu Z
    Tumour Biol; 2016 Feb; 37(2):2425-33. PubMed ID: 26383521
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [siRNA-mediated CDK6 knockdown suppresses nasopharyngeal carcinoma cell growth and cell cycle transition in vitro].
    Luo X; Xia Q; Qin J; Huang Y; Liu J; Wang Y; Wang H; Chen J
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jun; 34(7):1071-4. PubMed ID: 25057088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. BRD7 suppresses the growth of Nasopharyngeal Carcinoma cells (HNE1) through negatively regulating beta-catenin and ERK pathways.
    Peng C; Liu HY; Zhou M; Zhang LM; Li XL; Shen SR; Li GY
    Mol Cell Biochem; 2007 Sep; 303(1-2):141-9. PubMed ID: 17458518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor suppressor BLU inhibits proliferation of nasopharyngeal carcinoma cells by regulation of cell cycle, c-Jun N-terminal kinase and the cyclin D1 promoter.
    Zhang X; Liu H; Li B; Huang P; Shao J; He Z
    BMC Cancer; 2012 Jun; 12():267. PubMed ID: 22727408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blockade of AP-1 activity by dominant-negative TAM67 can abrogate the oncogenic phenotype in latent membrane protein 1-positive human nasopharyngeal carcinoma.
    Jin X; Song X; Li L; Wang Z; Tao Y; Deng L; Tang M; Yi W; Cao Y
    Mol Carcinog; 2007 Nov; 46(11):901-11. PubMed ID: 17477349
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-16 targets fibroblast growth factor 2 to inhibit NPC cell proliferation and invasion via PI3K/AKT and MAPK signaling pathways.
    He Q; Ren X; Chen J; Li Y; Tang X; Wen X; Yang X; Zhang J; Wang Y; Ma J; Liu N
    Oncotarget; 2016 Jan; 7(3):3047-58. PubMed ID: 26655091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways.
    Zhou J; Ma J; Zhang BC; Li XL; Shen SR; Zhu SG; Xiong W; Liu HY; Huang H; Zhou M; Li GY
    J Cell Physiol; 2004 Jul; 200(1):89-98. PubMed ID: 15137061
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.